• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Heterocyclic Compounds

Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate (CAS No. 2199-59-9): A Versatile Intermediate in Modern Pharmaceutical Synthesis

Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate (CAS No. 2199-59-9) is a significant intermediate in the realm of pharmaceutical synthesis, playing a crucial role in the development of various therapeutic agents. This compound, characterized by its unique pyrrole core structure, has garnered considerable attention due to its versatility and utility in synthetic chemistry.

The molecular structure of Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate consists of a pyrrole ring substituted with a formyl group at the 5-position and methyl groups at the 2- and 4-positions, further esterified at the 3-position with an ethyl group. This specific arrangement imparts distinct reactivity patterns, making it a valuable building block for constructing more complex molecules.

In recent years, the pharmaceutical industry has seen a surge in the demand for novel heterocyclic compounds, particularly those derived from pyrrole scaffolds. Pyrroles are known for their broad biological activity and are integral to many drugs used in treating conditions ranging from infectious diseases to cancer. The synthesis of derivatives like Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate has become increasingly sophisticated, leveraging advanced synthetic methodologies to enhance yield and purity.

The formyl group in Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate serves as a versatile handle for further functionalization. It can undergo condensation reactions with various nucleophiles, allowing for the introduction of additional functional groups such as amines or alcohols. This reactivity is particularly useful in constructing complex drug molecules where multiple functional groups need to be incorporated efficiently.

Moreover, the presence of methyl groups at the 2- and 4-positions influences the electronic properties of the pyrrole ring, affecting its interactions with biological targets. These substituents can modulate the compound's solubility, metabolic stability, and binding affinity, making them critical factors in drug design. The ethyl ester group at the 3-position also contributes to the overall reactivity and stability of the molecule, providing another layer of flexibility in synthetic transformations.

Recent studies have highlighted the importance of Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate in the development of antiviral and anticancer agents. For instance, researchers have utilized this compound as a precursor in synthesizing novel pyrrole-based inhibitors targeting viral proteases and kinases. The ability to modify its structure allows for fine-tuning of pharmacological properties, leading to more effective therapeutic outcomes.

The synthesis of Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate typically involves multi-step organic reactions starting from readily available pyrrole derivatives. Advanced catalytic methods and green chemistry principles have been increasingly employed to improve efficiency and minimize environmental impact. For example, transition metal-catalyzed cross-coupling reactions have enabled more streamlined routes to complex pyrrole derivatives without excessive waste generation.

In conclusion, Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate (CAS No. 2199-59-9) represents a cornerstone in modern pharmaceutical synthesis. Its unique structural features and reactivity make it an indispensable tool for medicinal chemists seeking to develop innovative therapeutic agents. As research continues to uncover new applications for this compound, its significance in drug discovery is poised to grow even further.

• 69687-80-5(Methyl 2,5-dimethyl-1H-pyrrole-3-carboxylate)
• 1721-13-7(ethyl 2,6-dimethylpyridine-3-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)